ArticleBMC public health2025
The shift in Mosquito-borne diseases incidence across Asia-Pacific region (1992-2021): insights from an Age-Period-Cohort analysis using the global burden of disease study 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of natural predators, microbial bioinsecticides, and plant-based bioinsecticides to reduce mosquito-borne disease burden: a systematic review.Journal of medical entomology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeMosquito-borne diseases (MBDs) pose a significant threat in the Asia-Pacific region, encompassing both the Western Pacific and South-East Asia. This study is aimed at improving the understanding of the evolution of incidence patterns of MBDs within the Asia-Pacific region and supporting the development of effective health policies.
methodsCase numbers, incidence, and age-standardized incidence rate (ASIR) of MBDs were obtained from the Global Burden of Disease Study 2021. Furthermore, an Age-Period-Cohort model was applied to characterize overall temporal trends in MBDs incidence and to assess the independent effects of age, period, and birth cohort. Decomposition analysis was used to quantify the extent to epidemiological changes, population growth, and aging contributed to the observed trends. Additional stratified analyses were performed by regions and country.
resultsFrom 1992 to 2021, the ASIR of MBDs in the Asia-Pacific region displayed regional heterogeneity. Overall, the net drift of ASIR indicated an annual increase of 1.07% per year in the Western Pacific region, rising from 292.26 to 380.84 per 100,000 population. In contrast, the South-East Asia region experienced an annual decrease of 1.88% per year, with ASIR declining from 3,779.81 to 1,856.84 per 100,000 population. Meanwhile, driven by population growth and epidemiological changes, dengue gradually replaced malaria as the predominant MBD in both regions. Dengue cases increased from 1,082,887 to 3,839,091 in the Western Pacific region and from 14,326,313 to 32,627,815 in the South-East Asia region, far exceeding the corresponding malaria cases (2,387,112 and 5,784,641). Age-Period-Cohort analysis further revealed distinct epidemiological patterns: South-East Asia exhibited favorable period and cohort effects, while the Western Pacific showed an unfavorable trend.
conclusionThe intensifying threat of MBDs in the Western Pacific region underscores the need for highly responsive and adaptive public health strategies, supported by ongoing regional collaboration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.